A person gets a dose of the coronavirus disease (COVID-19) vaccination of BioNTech and Pfizer in this undated handout photo, as Britain became the first western country to approve a COVID-19 vaccine, in Mainz, Germany.
BioNTech SE 2020, all rights reserved/Handout via REUTERSGENEVA (Reuters) - EU regulators have reached out to their British counterparts to share information from their review of Pfizer Inc’s COVID-19 vaccine, a WHO medical expert said on Thursday.
Britain approved the vaccine on Wednesday, jumping ahead of the rest of the world in the race to begin the most crucial mass inoculation programme in history.
Prime Minister Boris Johnson touted the green light from Britain’s medicine authority as a global win though he recognised the logistical challenges of vaccinating an entire country of 67 million.
U.S. and EU regulators are sifting through the same Pfizer vaccine trial data, but have yet to give their approval.
Pfizer Inc’s, Boris Johnson
Pfizer, BioNTech, REUTERS GENEVA, British, Pfizer Inc’s COVID
Britain, Mainz, Germany